Product Details

Teva-Naproxen EC

Naproxen
500 mg
Enteric Coated Tablet


DIN/PIN/NPN

02243314

Manufacturer

Teva Canada Limited

Formulary Listing Date

2008-11-04  

Unit Price

0.6894

Amount MOH Pays

NA

Coverage Status

Off-Formulary Interchangeable

ODB Formulary Therapeutic Classification

Therapeutic Note

Naproxen 500 mg Enteric-Coated Tablet: NSAIDs have a high rate of serious adverse effects in the elderly. When prescribing NSAIDs, the minimal effective dose for the shortest period of time should be used. In nonspecific pain and/or osteoarthritis, in the absence of joint inflammation (swelling), acetaminophen is a better first choice for analgesia. The most effective treatment to prevent NSAID-gastritis is misoprostol; although H-2 antagonists, such as ranitidine or cimetidine, are commonly used, they are not as effective. NSAIDs can significantly aggravate hypertension and congestive heart failure; ASA in doses below 1 gram per day is a better choice than other NSAID options if anti-inflammatory effects are required in patients with these conditions. Low dose ASA has additional benefits for anti-platelet indications that are not provided by other NSAIDs, and should be given in preference or in addition to other NSAIDs for patients with vascular indications.

ATC Code

M01AE02

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02243314 Teva-Naproxen EC 0.6894 NA
02294710 PMS-Naproxen EC 0.6894 NA
02350807 Naproxen EC 0.6894 NA
02162423 Naprosyn E NA NA
02246701 Apo-Naproxen EC 0.6894 NA
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph